DexCom (DXCM) Tops Q4 EPS by 7c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.65 +0.13%
Revenue Growth %: +9.9%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +9.9%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
(Updated - February 8, 2024 4:46 PM EST)
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.50, $0.07 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
DexCom sees FY2024 revenue of $4.15-4.35 billion, versus the consensus of $4.33 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- General Mills beats estimates as cost savings offset volumes
- Activist Jana Partners calls for Six Flags sale - WSJ
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
